(VCBeat) Mar. 16, 2021 -- Beijing Julu Medical Management Co., Ltd. ("Julu Medical"), a solution provider of cardiopulmonary rehabilitation, recently completed a Series A financing of tens of millions from Yijing Capital. Previously, Julu Medical has obtained investment from Med-Fine Capital, Tianyi Group, Danen Capital, and other well-known investors.

About this round of financing, Xu Changjun, chairman of Julu Medical, said: "The funds raised will mainly be used for the expansion and construction of our rehabilitation center, the R&D of digital devices and hardware, and the construction of the marketing and operation team. In addition, relying on capital support and technological breakthroughs, Julu Medical will further promote the development of the cardiopulmonary rehabilitation market in China, so that more patients with cardiopulmonary diseases can benefit and keep vitality and health."

Julu Medical is a rehabilitation medical company focusing on systematic construction and operation of cardiopulmonary rehabilitation, which owns Beijing Julu Medical Rehabilitation Center Co., Ltd. and Hangzhou Julu Medical Device Co., Ltd. Julu Medical has also obtained the certificates of the national high-tech technology enterprise and the Zhongguancun high-tech enterprise.

Through a long-term accumulation of experience, Julu Medical has established an academic exchange center for cardiopulmonary rehabilitation in cooperation with academies, academic leaders and first-class hospitals at grade 3. At the same time, as a training and learning base, Julu Medical provides complete solutions of talents training, system management, equipment, operation plan, etc., to promote the construction of cardiopulmonary rehabilitation centers in China. Up to now, Julu Medical has received more than 60 patents. 

Founded in 2015, Yijing Capital conducts primary market equity investment and parent fund investment with its own capital and private equity funds. The company focuses on early and growth-stage investments in medical care, TMT & big consumption, and science and technology.

Founded in 2014 at China's financial hub-Shanghai, Med-Fine Capital is an investment fund. Currently, it manages11 investment funds, of which the amount value has reached nearly 800 million yuan.